New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...

Q2 2025 Earnings Call Transcript July 29, 2025 Alkermes plc beats earnings expectations. Reported EPS is $0.517, expectations ...

Alkermes (ALKS) reports strong Q2 2025 results with 14% growth, robust finances, and positive Phase II narcolepsy data.

In late November, Georgia beat Georgia Tech in a heart-stopping, eight-overtime classic. In one of the most exciting games of the entire colle ...